U.S. Insurance Stock News

NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

What Nuvalent (NUVL)'s FDA NDA Filing for Neladalkib in ALK-Positive NSCLC Means For Shareholders

Nuvalent, Inc. recently submitted a New Drug Application to the U.S. FDA for neladalkib, an investigational ALK-selective inhibitor for TKI pre-treated advanced ALK-positive non-small cell lung cancer, supported by Phase 1/2 ALKOVE-1 trial data showing encouraging activity and a generally well-tolerated safety profile. The filing is bolstered by neladalkib’s breakthrough therapy and orphan drug designations, underscoring its potential role in addressing difficult-to-treat ALK-positive NSCLC...
NYSE:OWL
NYSE:OWLCapital Markets

Has Blue Owl Capital (OWL) Fallen Too Far After Its 45% Year To Date Share Price Drop

Investors may be wondering whether Blue Owl Capital's current share price reflects its underlying value, or if the recent pullback has gone too far. The stock last closed at US$8.28, with a 3.4% decline over 7 days, a 12.5% decline over 30 days, and a 45.9% decline year to date. This adds up to a 49.0% decline over the past year and a 12.8% decline over 3 years, while the 5-year return sits at 1.2%. Recent coverage of Blue Owl Capital has focused on its position within the wider capital...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Is Skyward Specialty Insurance Group (SKWD) Pricing Reflect Its Recent Share Price Slide And Volatility

If you are wondering whether Skyward Specialty Insurance Group at around US$45.89 is offering fair value or a potential bargain, this article will help you put the current share price in context. The stock has risen 4.5% over the last 7 days, while returns sit at a 0.9% decline over 30 days, a 5.6% decline year to date and a 12.0% decline over the past year, compared with a very large 3-year return of 117.7%. Recent coverage has focused on Skyward Specialty Insurance Group's role within the...
NYSE:AXTA
NYSE:AXTAChemicals

Axalta Coating Systems (AXTA) Is Up 6.3% After Raising 2024 Guidance and Detailing 2026 Results Plans

Axalta Coating Systems recently updated investors by lifting its first-quarter and full-year 2024 guidance and scheduling the release of its first-quarter 2026 financial results, which will be accompanied by a conference call and year-long webcast replay for stakeholders. This combination of improved guidance and enhanced transparency around upcoming results highlights how Axalta is trying to reinforce confidence in its operational execution and demand trends across its coatings...
NYSE:JBL
NYSE:JBLElectronic

Is It Too Late To Consider Jabil (JBL) After Its 122% One Year Surge

If you are wondering whether Jabil’s current share price still offers value after a strong run, this breakdown will help you understand what you are really paying for. At a last close of US$293.02, Jabil has returns of 9.1% over 7 days, 16.7% over 30 days, 21.9% year to date and 122.3% over 1 year, plus a very large 3 year gain and around 4.5x over 5 years that may be reshaping expectations. Recent coverage has focused on Jabil’s role in electronics manufacturing and how investors are...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris And Xoople AI Constellation Adds New Angle To Valuation Story

L3Harris Technologies (NYSE:LHX) and Xoople announced an AI optimized satellite constellation after seven years of co development. The constellation is designed for next generation Earth observation and spatial intelligence tailored to AI driven analytics. The partners aim to deliver gains in data quality, precision, and speed compared with existing commercial systems. L3Harris, known for defense, communications, and space systems, is now stepping further into AI focused geospatial data...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Is Kodiak AI (KDK) Pricing Reflect Future Cash Flow Potential After Recent Share Price Slide

Wondering if Kodiak AI at US$7.85 is a bargain or a value trap? This article walks through what the current price could be saying about the stock. The share price has moved 9.0% over the last 7 days, after a 9.5% decline over 30 days and a 27.5% fall year to date, with the 1 year return at 29.7% in the red. Recent coverage has focused on Kodiak AI as part of broader discussions about listed auto related and AI exposed names, with investors weighing business potential against ongoing...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

A Look At CoStar Group (CSGP) Valuation As AI Concerns And Weaker Earnings Forecast Pressure Sentiment

CoStar Group (CSGP) is under pressure after a weaker earnings forecast and rising concerns that AI tools could challenge its proprietary real estate data platforms, even as reported revenue growth and industry position remain strong. See our latest analysis for CoStar Group. That concern is visible in the price action, with a 1 month share price return of 19.45% and a 90 day share price return of 36.19%. These gains contribute to a 50.52% 1 year total shareholder return decline as momentum...
NYSE:NOMD
NYSE:NOMDFood

Does Nomad Foods’ New Regional Structure Sharpen Its European Strategy And Investment Story (NOMD)?

Nomad Foods has recently reshaped its European leadership, appointing Jon Fernandez de Barrena as president for southern Europe and planning a separate president for central Europe to sharpen commercial execution across key markets including France, the Netherlands, Italy, Spain, the Nordics and the DACH region. This regional leadership structure could materially influence how effectively Nomad Foods executes its frozen-food strategy across diverse consumer preferences, regulatory regimes...
NYSE:TNC
NYSE:TNCMachinery

Is Tennant (TNC) Quietly Redefining Its Competitive Edge With AI-Powered Industrial Cleaning?

Tennant Company recently launched the X16 SWEEP, an autonomous robotic sweeper for complex industrial environments, powered by Brain Corp’s BrainOS platform and available for purchase from April 7, 2026. This debut from Tennant’s new autonomous robotics organization highlights a deeper push into AI-enabled cleaning solutions that could reshape its longer-term business mix. We’ll now explore how the X16 SWEEP’s AI-driven industrial automation focus might influence Tennant’s existing...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Is Rambus (RMBS) Quietly Recasting Its Story Around AI Infrastructure With This Earnings Call?

Rambus Inc. recently announced it will host a webcast conference call on April 27, 2026, to review its first-quarter fiscal 2026 results, with a replay available for one week on its investor relations website. This update comes as Rambus is increasingly viewed as a key intellectual property supplier for AI-focused memory and connectivity, aligning its business model with broader AI infrastructure buildouts rather than isolated chip sales. We’ll now examine how Rambus’s positioning as an...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Canadian Review And FERC Ruling Shape Plains All American Cash Flows

The Canadian Competition Bureau has escalated its review of Keyera's proposed purchase of Plains All American Pipeline's Canadian NGL business, adding more regulatory scrutiny to the transaction. Separately, Plains All American Pipeline received Federal Energy Regulatory Commission approval for its proposed accounting treatment related to the Cactus III pipeline acquisition. These developments affect Plains All American Pipeline's asset mix and the timing of its planned shift toward more fee...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Is Wintrust Financial’s (WTFC) Moderating Growth Changing How Investors View Its Capital Resilience?

In recent commentary, analysts have flagged that Wintrust Financial’s revenue growth has cooled compared with its earlier trajectory and that net interest income is projected to fall over the coming year. At the same time, the bank’s Tier 1 capital ratio, averaging 9.9% over the last two years, is drawing scrutiny for potential vulnerability in tougher economic conditions, prompting a more cautious stance among investors. Next, we’ll examine how concerns about slowing revenue and forecast...
NYSE:SAM
NYSE:SAMBeverage

Is Boston Beer Company (SAM) Fairly Priced After Its Strong Year To Date Rally?

Wondering whether Boston Beer Company's current share price actually reflects its underlying worth, or if the market is missing something important about this brewer? The stock last closed at US$260.05, with returns of 8.0% over 7 days, 11.3% over 30 days, 30.1% year to date, 7.0% over 1 year, negative 18.7% over 3 years, and negative 79.9% over 5 years. This mix can change how investors think about both potential and risk. These moves sit against a backdrop of ongoing attention on Boston...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini (TPC) Valuation Check After Strong Recent Share Price Momentum

Tutor Perini (TPC) has been drawing investor attention after recent share price moves, with the stock showing double digit total returns over the past year and past 3 months. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Tutor Perini. Recent trading has been strong, with a 14.3% 1 month share price return and a 17.5% year to date share price return, alongside a very large 1 year total shareholder return that points to building momentum from earlier...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ (LKQ) Is Up 6.6% After Launching Strategic Review Including Possible Sale Of The Company

LKQ Corporation recently announced a broad strategic review that could include a full sale of the business, marking a major shift in its corporate direction. Palm Valley Capital Management highlighted this review as a potential catalyst to close what it sees as a valuation gap between LKQ and its underlying fundamentals. We’ll now explore how LKQ’s potential sale review could reshape the company’s cost-cutting-driven investment narrative and longer-term earnings outlook. Capitalize on the AI...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab’s Mars Contracts Add New Angle To Deep Space Growth Story

Rocket Lab (NasdaqCM:RKLB) has been selected by NASA to study a new Mars relay architecture that could support future missions to the Red Planet. The company is also in the running for NASA's Mars Telecommunications Network contract, a potential multi year role in providing deep space communications infrastructure. For investors tracking space infrastructure, this is a fresh angle on Rocket Lab beyond its launch and spacecraft services. The stock closed at $66.74, with a very large 1 year...
NYSE:ETR
NYSE:ETRElectric Utilities

Is It Too Late To Consider Entergy (ETR) After Its 50% One Year Share Price Jump?

Investors may be wondering whether Entergy at around US$117 a share still offers value, or if most of the easy upside is already on the table. The stock last closed at US$117.44, with returns of 2.2% over 7 days, 12.1% over 30 days, 25.1% year to date and 50.3% over 1 year. These figures naturally raise questions about what is already priced in and how much risk investors are taking on at these levels. Recent coverage has focused on Entergy as a regulated utility with an established role in...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal Taps Canva And Meta As Creator Commerce Weighs On Valuation

PayPal Holdings (NasdaqGS:PYPL) has launched direct Payment Links integration with Canva, allowing creators to embed global checkout and payments inside their designs. In a separate move, PayPal announced a partnership with Meta to power one tap commerce on Facebook and explore potential use of its PYUSD stablecoin in social commerce. These partnerships broaden PayPal's role in creator and social commerce payments across Canva's 265 million monthly users and Meta's social platforms. For...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

A Look At Trupanion (TRUP) Valuation After Recent Share Price Volatility

Trupanion stock: recent performance snapshot Trupanion (TRUP) has drawn attention after a period of mixed share performance, with the price at $25.67 and returns showing a 1 day gain alongside weaker moves over the month and past 3 months. See our latest analysis for Trupanion. That small recent lift in the share price comes after a much tougher stretch, with the 90 day share price return at a 28.85% decline and the 1 year total shareholder return at a 31.98% loss, suggesting momentum has...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

A Look At Snap (SNAP) Valuation As Activist Investors Press For Major Changes

Snap (SNAP) is under fresh scrutiny after activist investors Randian Capital and Irenic Capital issued public letters pressing for changes in capital allocation, governance, AI focus, and the future of its Spectacles business. See our latest analysis for Snap. The activist letters arrive at a tense moment for shareholders, with a 90 day share price return of 39.71% and a 1 year total shareholder return of 36.78%, following a 5 year total shareholder return decline of 92.25%. If you are...
NYSE:NGL
NYSE:NGLOil and Gas

Why NGL Energy Partners (NGL) Is Up 5.3% After Authorizing a $100 Million Unit Buyback – And What's Next

NGL Energy Partners LP announced on April 9, 2026 that its Board of Directors authorized an open-ended unit repurchase program of up to US$100,000,000 of its outstanding limited partnership interests. This sizable buyback authorization highlights management’s willingness to deploy capital toward reducing the unit count, which can meaningfully affect existing unitholders’ ownership exposure. We’ll now examine how this US$100,000,000 repurchase plan may shape NGL Energy Partners’ investment...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

A Look At Corcept Therapeutics (CORT) Valuation After FDA Letter And Class Action Lawsuits

Corcept Therapeutics (CORT) is back in focus after the FDA issued a Complete Response Letter for relacorilant, followed by securities class action filings that question past disclosures around the drug’s approval prospects. See our latest analysis for Corcept Therapeutics. Corcept’s share price has rebounded to US$42.25, with a 30-day share price return of 25.97% and a 90-day gain of 12.67%, even though the 1-year total shareholder return is still down 37.62%. If this kind of sharp move after...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

What Amgen (AMGN)'s TEPEZZA On‑Body Injector Phase 3 Results Mean For Shareholders

Amgen recently reported positive Phase 3 results for a subcutaneous, on-body injector version of TEPEZZA in moderate-to-severe active Thyroid Eye Disease, showing a statistically significant 77% proptosis response rate over 24 weeks versus placebo with a safety profile broadly in line with the existing IV formulation. This progress toward a more convenient delivery option could be important for patient adoption and may influence how Amgen’s thyroid eye disease franchise competes against...